by Jordana Choucair | Jun 21, 2022 | Life Sciences
fizer agreed to invest $95 million to buy an 8.1 percent percent stake in French vaccines company Valneva. Pfizer and Valneva previously partnered to create a joint Lyme disease program, which is developing a Lyme disease vaccine candidate called VLA15. Valneva is...
by Jordana Choucair | Jun 21, 2022 | M&A
A UnitedHealth Group unit plans to acquire EMIS Group – a U.K. health technology company that focuses on primary care and pharmacy systems. UnitedHealth’s Optum UK executives said that the deal, valued at $1.5 billion, will bring more advanced technology...
by Jordana Choucair | Jun 21, 2022 | Payers
New research published in the Annals of Internal Medicine found that Medicare could have saved almost $4.0 billion if it were purchasing generic drugs directly from the Mark Cuban Cost Plus Drug Company (MCCPDC) online pharmacy. Specifically, Medicare could have saved...
by Jordana Choucair | Jun 21, 2022 | Public Health/Prevention
The Commonwealth Fund Commission on a National Public Health System, a bipartisan panel made up of leading former health officials, called for an overhaul of the U.S. public health system. The panel said that change is necessary to protect against health risks such as...
by Jordana Choucair | Jun 17, 2022 | Access & Coverage
The Centers for Medicare & Medicaid Services (CMS) announced it has approved postpartum coverage expansion plans for three additional states plus the District of Columbia. The approvals to Maine, Minnesota, New Mexico bring the total number of states that have...
by Jordana Choucair | Jun 17, 2022 | D.C. News
A new deal on COVID-19 funding is in doubt after top Republican senators questioned the need for additional funding. Senator Richard Burr pledged to be a “roadblock” until the officials provide sufficient justification that the money is needed. Senator Mitt Romney...
Recent Comments